August 27, 2018
AdipoGen Life Sciences and Suzhou Bright Scistar Biotechnology (BSBIO) Partner on Commercializing BSBIO’s Human ELISA Kits and Validated Monoclonal Antibodies
Adipogen Life Sciences, Inc. (AdipoGen) announced today that it entered into a R&D and Marketing agreement with Suzhou Bright Scistar Biotechnology Co., Ltd. (BSBIO) to commercialize internationally BSBIO’s proprietary human ELISA Kits and validated monoclonal antibodies in the research fields of cancer and immune checkpoint proteins. In addition the companies will co-develop key biologicals with therapeutic and diagnostic potential.
AdipoGen (www.adipogen.com) is a manufacturer and international distributor of innovative life science research reagents and of GMP-grade proteins (enhanced cytokines) based in the U.S. and Switzerland. BSBIO is based in Suzhou, China and works closely with the Soochow University Medical and Biological Technology Institute and Jiangsu Clinical Immunology Institute. BSBIO’s 20 researchers continue to develop clinically relevant human ELISA Kits and validated monoclonal antibodies to accelerate the advancement of research in immunology and immunotherapy.
Xueguang Zhang, Chairman and Chief Scientist of BSBIO called the deal a very strategic collaboration which offers BSBIO more exposure in the Chinese market and more access to the international market. Combining the R&D efforts of AdipoGen and BSBIO will provide economical, innovative and state of the art tools supporting life science research, worldwide.